Head-to-head · WeighScore
AbundRX vs LeanDose
The verdict
LeanDose takes it — 67.1/100 to 66.6/100, but only just.
LeanDose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LeanDose is a doctor-guided compounded GLP-1 telehealth service for eligible adults, with transparent all-inclusive first-month pricing: compounded semaglutide from $159 and tirzepatide from $279. AbundRX is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AbundRX | LeanDose |
|---|---|---|
| WeighScore | 66.6/100 | 67.1/100 |
| Grade | C | C |
| Scorecard rank | #181 | #167 |
| Semaglutide | $179/mo (compounded) | $159/mo (first-month rate, compounded) |
| Tirzepatide | $279/mo (compounded) | $279/mo (first-month rate, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #181 · C
Strengths
- Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
- Fast, free shipping and a simple few-minute online health assessment
- Provider-guided care connecting patients with licensed US clinicians
- Publishes Terms, Privacy, and Refund policies
Where it loses points
- Claims LegitScript certification in text but displays no verifiable seal or listing
- Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Compounding pharmacy not named; no HIPAA notice found; state availability not published
- Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
Graded #167 · C
Strengths
- Transparent all-inclusive first-month pricing (compounded semaglutide from $159, tirzepatide from $279)
- Verifiable LegitScript certification (seal ID 49840868) and an FDA-registered compounding pharmacy
- Doctor-prescribed and supervised, with personalized care plans and multi-state clinical support
- Convenient at-home delivery; compounded semaglutide and tirzepatide options
- Honest, modest social proof — 119 five-star patient reviews
Where it loses points
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Headline rates are first-month pricing; your ongoing monthly cost may be higher
- Available in multiple states but the full list is not published on the homepage
- The compounding pharmacy is FDA-registered but not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.